|
Magnesium in PDB 5uoy: Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)Enzymatic activity of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)
All present enzymatic activity of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One):
3.1.4.17; Protein crystallography data
The structure of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One), PDB code: 5uoy
was solved by
E.P.Cedervall,
C.K.Allerston,
R.Xu,
V.Sridhar,
R.Barker,
K.Aertgeerts,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5uoy:
The structure of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One) also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)
(pdb code 5uoy). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One), PDB code: 5uoy: Magnesium binding site 1 out of 1 in 5uoyGo back to Magnesium Binding Sites List in 5uoy
Magnesium binding site 1 out
of 1 in the Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)
Mono view Stereo pair view
Reference:
B.Dyck,
B.Branstetter,
T.Gharbaoui,
A.R.Hudson,
J.G.Breitenbucher,
L.Gomez,
I.Botrous,
T.Marrone,
R.Barido,
C.K.Allerston,
E.P.Cedervall,
R.Xu,
V.Sridhar,
R.Barker,
K.Aertgeerts,
K.Schmelzer,
D.Neul,
D.Lee,
M.E.Massari,
C.B.Andersen,
K.Sebring,
X.Zhou,
R.Petroski,
J.Limberis,
M.Augustin,
L.E.Chun,
T.E.Edwards,
M.Peters,
A.Tabatabaei.
Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties. J. Med. Chem. V. 60 3472 2017.
Page generated: Mon Dec 14 21:16:42 2020
ISSN: ISSN 1520-4804 PubMed: 28406621 DOI: 10.1021/ACS.JMEDCHEM.7B00302 |
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |